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Abstract
We have isolated a Xenopus lae˝is genomic sequence distinct from, but sharing high sequence similarity with
N-cadherin. We present evidence that the gene represented by this sequence, named XNcad3, resides at a separate locus to
the two previously isolated N-cadherin clones from this species. Extensive analysis could detect no expression of XNcad3
in embryonic or adult tissues. It seems likely that XNcad3 represents a non-expressed pseudogene, or perhaps a novel
cadherin with a restricted expression pattern.
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The cadherins constitute a large family of related
transmembrane calcium-dependent cell adhesion
molecules. The members of this family often exhibit
specific spatial and temporal expression patterns and
are thus considered to be key morphological regula-
w w xxtors within developing organisms reviewed 1,2 . In
Xenopus lae˝is, N-cadherin is expressed as an early
response to neural induction and subsequently during
the formation of the neural plate and the neural tube
w x3 . Its regulation and expression is therefore of im-
portance in the study of the developing nervous
system.
Whilst screening a X. lae˝is genomic library
 .lambda Fix II-Stratagene, La Jolla, CA to isolate
N-cadherin clones for subsequent promoter analysis,
we have isolated a novel N-cadherin related gene
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 .named XNcad3. Database analysis FastA identified
only the two previously described X. lae˝is N-
w xcadherin clones 3–5 as sharing high sequence simi-
larity with XNcad3. These two clones named XN-
 w x.cad1 and XNcad2 nomenclature 3 are thought to
represent pseudoallelic copies of the N-cadherin gene
which arose as a consequence of the pseudotetraploid
w xnature of the X. lae˝is genome 6 . XNcad3 is how-
ever distinct from XNcad1 and XNcad2. Nucleotide
 .sequence alignment of XNcad3 genomic clone with
 .  .XNcad1 cDNA clone and XNcad2 cDNA clone is
shown in Fig. 1 blocks 1–10 , with the first base of
the initiating ATG of XNcad1 and XNcad2 being
q1. The region q1 to q72 is highly similar be-
tween the three sequences at the nucleotide level, and
 .also when translated Fig. 1 bottom block . The
breakdown in homology between XNcad3 and XN-
cad1r2 3X to q72, bearing in mind that genomic and
cDNA sequences are being compared, may suggest
that an XNcad3 intron begins at this position. This
view is supported by the observations that stop codons
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Fig. 1. Blocks 1–10: multiple nucleotide sequence alignment of XNcad1, XNcad2, XNcad3 and XBNcad3 using the GCG package. The
first base of the initiation codon is numbered as q1. Bases conserved between the sequences are boxed. Bottom block: multiple amino
acid sequence alignment of the proteins encoded by XNcad1, XNcad2, XNcad3 and XBNcad3 using the GCG package. The alignment
begins from the initiating methionine. Amino acids conserved between the sequences are boxed.
occur in all three reading frames of XNcad3 between
q72 and q141, and by the presence of a possible 3X
splice site between q67 and q75 consensus: arc-a-
.g-g-t-arg-a-g-t; XNcad3: c-a-t-g-g-a-g-a-g . It should
also be noted that the 3X splice site of exon1 of mouse
and human N-cadherin is found at a similar position
 . w xq60 7,8 . XNcad3 also shares a region of high
sequence similarity with the 5X untranslated regions
of XNcad1 and XNcad2, especially in the sequences
immediately 5X to the initiation codon. Sequence
homology in non-coding regions implies a close evo-
lutionary relationship between XNcad3, XNcad1 and
XNcad2.
Analysis of the nucleotide sequences of XNcad1,
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XNcad2 and XNcad3 suggests that XNcad3 does not
represent either an allelic or pseudoallelic variant of
the N-cadherin gene in X. lae˝is. It has previously
been argued that XNcad1 and XNcad2 represent
pseudoallelic copies of the N-cadherin gene in X.
w xlae˝is 5 . This argument is supported by observa-
tions from Southern analysis of X. lae˝is genomic
DNA which suggest that both XNcad1 and XNcad2
w xexist as two copies within the X. lae˝is genome 5 .
 .Dendographic analysis GCG of the nucleotide
 .alignment shown in Fig. 1 blocks 1–10 confirms
that XNcad1 and XNcad2 are more closely related to
 .each other than to XNcad3 data not shown . Allelic
copies of a gene are likely to show higher sequence
similarity than pseudoallelic copies of a gene. It
therefore follows that if XNcad1 and XNcad2 are the
pseudoalleles, XNcad3 cannot be a pseudoallele, and
is very unlikely to be an allelic copy of XNcad1 or
XNcad2. This suggests that XNcad3 represents a
novel N-cadherin gene within the X. lae˝is genome.
To further investigate this hypothesis it was first
decided to determine if XNcad1, XNcad2 and XN-
cad3 sequences could be isolated from the genomic
DNA of a single X. lae˝is individual. PCR primers
were designed to regions of the 5X untranslated of
each gene to allow the amplification of small region
of the 5X untranslated sequences. The primers were
designed as not to cross hybridise between the three
sequences. Fig. 2 shows the result of the PCR
amplification of the three sequences. It was possible
to isolate PCR amplimers for all three sequences.
These bands were further analysed by Southern blot
 .and sequencing data not shown to unequivocally
prove that each fragment represented the expected
sequence. This further supports the suggestion that
XNcad3 represents a gene found at a separate locus
to XNcad1 and XNcad2, and is therefore not a poly-
morphic variant of either.
The expression pattern of XNcad3 was analysed to
determine whether the gene was expressed in a pat-
tern resembling that of XNcad1 and XNcad2. XN-
cad1 and XNcad2 have identical expression patterns
w x5 . Fig. 3 shows the result of an RNase protection
assay to determine the expression pattern of XNcad3.
A control antisense probe derived from the sequences
y190 to q93 q1 being the first base of the
.initiation codon of XNcad1 detected a temporal ex-
pression pattern for this gene as previously described
Fig. 2. PCR amplification of XNcad1, XNcad2 and XNcad3
sequences from the genomic DNA of an individual frog. Gene
specific primers designed to the 5X untranslated region of
XNcad1,2 and 3 were used to amplify sequences from the
genomic DNA of an individual frog. Bands of the predicted sizes
were observed. No DNA controls were included for each set of
primers.
w x3–5 . However an antisense probe derived from a
 .similar region of XNcad3 y417 to q65 failed to
detect expression in a series of developing embryos
from egg to tadpole. This probe contains the region
homologous to the 5X untranslated region of XNcad1
and XNcad2 and 65 bases of the putative XNcad3
exon 1 open reading frame. Therefore a protected
band of at least 65 bases but probably longer be-
X .cause of 5 untranslated sequences would be pre-
dicted if expression were detectable. No such band
was observed, even after longer exposures of the
autoradiograph. Subsequently expression of XNcad3
could not be detected in a range of adult tissues
 .heart, brain, muscle and liver , wheras XNcad1 ex-
pression was detected in the heart and brain data not
.shown .
The observations made above that XNcad3 shares
high sequence similarity with XNcad1 and XNcad2,
but has no detectable expression suggests two likely
explanations for the existence of XNcad3. It is possi-
ble that XNcad3 represents a gene closely related to
N-cadherin which exhibits a very restricted expres-
sion pattern, or is expressed at an undetectable level
by the methods used. Alternatively, and perhaps more
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Fig. 3. Expression of XNcad1 and XNcad3 in developing embryos. 20 mg of total RNA from a series of developing embryos were used
in an RNase protection analysis with radiolabelled synthetic RNA gene specific probes as described in the text.
likely, XNcad3 may represent a non-expressed N-
cadherin pseudogene.
We have also isolated a X. borealis genomic clone
w xsharing high sequence similarity to N-cadherin 9,10 .
This clone named XBNcad3 shows somewhat better
sequence similarity to XNcad3 79.25 amino acid
.  .identity than XNcad1 58.3% amino acid identity or
 .XNcad2 66.7% amino acid identity in the putative
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 .coding region Fig. 1 bottom block . In addition, the
nucleotide sequence of XBNcad3 and XNcad3 3X to
 .the putative splice site at q72 Fig. 1 blocks 1–10
shows a high degree of identity. As described previ-
ously, the homology between XNcad3 and both XN-
cad1 and XNcad2 breaks down at this point. XBN-
cad3 expression cannot be detected, although N-
cadherin expression can be detected in X. borealis
w x10 . These observetions strongly suggest, therefore,
that an XNcad3 homologue exists in X. borealis, and
that if XNcad3 is a pseudogene it arose prior to the
divergence of X. lae˝is and X. borealis, an event
which is thought to have occurred between 10 and 20
w xmillion years ago 11 .
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